Tissue factor as a novel marker for detection of circulating cancer cells

Biomarkers

Volumn 16, Issue 1, 2011, Pages 58-64

  Otero, L L ^a   Alonso, D F ^a   Castro, M ^b   Cinat, G ^b   Gabri, M R ^a   Gomez, D E ^a  

^a UNIVERSIDAD NACIONAL DE QUILMES   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Biomarker; breast cancer; nested PCR; RT PCR; tissue factor

Indexed keywords

THROMBOPLASTIN;

ARTICLE; BLOOD SAMPLING; BREAST CARCINOMA; CANCER CELL; CANCER DIAGNOSIS; CANCER GROWTH; CELL STRAIN MCF 7; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOPEROXIDASE STAINING; IN VITRO STUDY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

BIOLOGICAL MARKERS; BREAST NEOPLASMS; CELL LINE, TUMOR; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; RECURRENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; THROMBOPLASTIN;

EID: 79251590259     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2010.533282     Document Type: Article

References (47)

1. Adamson AS, Luckert P, Pollard M, Snell ME, Amirkhosravi M, Francis JL. (1994). Procoagulant activity may be a marker of the malignant phenotype in experimental prostate cancer. Br J Cancer 69(2):286-90.
2. Belting M, Dorrell MI, Sandgren S, Aguilar E, Ahamed J, Dorfeutner A, Carmeliet P, Mueller BM, Friedlander M, Ruf W. (2004). Regulation of angiogenesis by tissue factor cytoplasmic domain signaling. Nat Med 10(5):502-9.
3. Boccaccio C, Comoglio PM. (2005). A functional role for hemostasis in early cancer development. Cancer Res 65(19):8579-82.
4. Bogdanov VY, Balasubramanian V, Hathcock J, Vele O, Lieb M, Nemerson Y. (2003). Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat Med 9(4):458-62.
5. Breitenstein A, Tanner FC, Lüscher TF. (2010). Tissue factor and cardiovascular disease: quo vadis? Circ J 74(1):3-12.
6. Rivers RP, Hathaway WE, Weston WL. (1975). Te endotoxin-induced coagulant activity of human monocytes. Br J Haematol 30(3):311-6.
7. Bromberg ME, Konigsberg WH, Madison JF, Pawashe A, Garen A.(1995). Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc Natl Acad Sci USA 92(18):8205-9.
8. Bromberg ME, Sundaram R, Homer RJ, Garen A, Konigsberg WH. (1999). Role of tissue factor in metastasis: functions of the cytoplasmic and extracellular domains of the molecule. Tromb Haemost 82(1):88-92.
9. Callander N, Rapaport SI. (1996). Trousseau's syndrome. West J Med 158(4):364-71.
10. Carrier M, Le Gal G, Wells PS, Fergusson D, Ramsay T, Rodger MA. (2008). Systematic review: the Trousseau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism? Ann Intern Med 149(5):323-33.
11. Chand HS, Ness SA, Kisiel W. (2006). Identifcation of a novel human tissue factor splice variant that is upregulated in tumour cells. Int J Cancer 118(7):1713-20.
12. Cunningham MA, Romas P, Hutchinson P, Holdsworth SR, Tipping PG. (1999). Tissue factor and factor VIIa receptor/ligand interactions induce proinfammatory efects in macrophages. Blood 94(10):3413-20.
13. Drake TA, Morrissey JH, Edgington TS. (1989). Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 134(5):1087-97.
14. Edgington TS, Mackman N, Fan ST, Ruf W. (1992). Cellular immune and cytokine pathways resulting in tissue factor expression and relevance to septic shock. Nouv Rev Fr Hematol 34 Suppl:S15-27.
15. Fleck RA, Rao LV, Rapaport SI, Varki N. (1990). Localization of human tissue factor antigen by immunostaining with monospecifc, polyclonal anti-human tissue factor antibody. Tromb Res 59(2):421-37.
16. Gabri MR, Vazquez V, Girón S, Castro MA, Cinat G, Gomez RE, Santoro FM, Gomez DE, Alonso DF. (2008). Molecular detection of circulating tyrosinase mRNA: optimization in a preclinical xenograft mouse melanoma model and further evaluation in samples from advanced melanoma patients. Int J Mol Med 21(5):555-9.
17. Gilbey AM, Burnett D, Coleman RE, Holen I. (2004). Te detection of circulating breast cancer cells in blood. J Clin Pathol 57(9):903-11.
18. Goldin-Lang P, Tran QV, Fichtner I, Eisenreich A, Antoniak S, Schulze K, Coupland SE, Poller W, Schultheiss HP, Rauch U. (2008). Tissue factor expression pattern in human non-small cell lung cancer tissues indicate increased blood thrombogenicity and tumour metastasis. Oncol Rep 20(1):123-8.
19. Guthmann MD, Castro MA, Cinat G, Venier C, Koliren L, Bitton RJ, Vázquez AM, Fainboim L. (2006). Cellular and humoral immune response to N-Glycolyl-GM3 elicited by prolonged immunotherapy with an anti-idiotypic vaccine in high-risk and metastatic breast cancer patients. J Immunother 29(2):215-23.
20. Hamada K, Kuratsu J, Saitoh Y, Takeshima H, Nishi T, Ushio Y (1996). Expression of tissue factor correlates with grade of malignancy in human glioma. Cancer 77(9):1877-83.
21. Jółkowska J, Derwich K, Dawidowska M. (2007). Methods of minimal residual disease (MRD) detection in childhood haematological malignancies. J Appl Genet 48(1):77-83.
22. Kirschmann DA, Seftor EA, Nieva DR, Mariano EA, Hendrix MJ. (1999). Diferentially expressed genes associated with the metastatic phenotype in breast cancer. Breast Cancer Res Treat 55(2):127-36.
23. Koomägi R, Volm M. (1998). Tissue-factor expression in human nonsmall-cell lung carcinoma measured by immunohistochemistry: correlation between tissue factor and angiogenesis. Int J Cancer 79(1):19-22.
24. Levi M, Keller TT, van Gorp E, ten Cate H. (2003). Infection and infammation and the coagulation system. Cardiovasc Res 60(1):26-39.
25. Levi M, van der Poll T, ten Cate H. (2006). Tissue factor in infection and severe infammation. Semin Tromb Hemost 32(1):33-9.
26. Li C, Colman LM, Collier ME, Dyer CE, Greenman J, Ettelaie C. (2006). Tumour-expressed tissue factor inhibits cellular cytotoxicity. Cancer Immunol Immunother 55(11):1301-8.
27. Mackman N, Morrissey JH, Fowler B, Edgington TS. (1989). Complete sequence of the human tissue factor gene, a highly regulated cellular receptor that initiates the coagulation protease cascade. Biochemistry 21;28(4):1755-62.
28. Mackman N. (2007). Alternatively spliced tissue factor-one cut too many? Tromb Haemost 97(1):5-8.
29. Mackman N. (2009). Te many faces of tissue factor. J Tromb Haemost 7 Suppl 1:136-9.
30. Mackman N. (2009). Te role of tissue factor and factor VIIa in hemostasis. Anesth Analg 108(5):1447-52.
31. Milsom C, Rak J. (2008). Tissue factor and cancer. Pathophysiol Haemost Tromb 36(3-4):160-76.
32. Mueller BM, Reisfeld RA, Edgington TS, Ruf W. (1992). Expression of tissue factor by melanoma cells promotes efcient hematogenous metastasis. Proc Natl Acad Sci USA 89(24):11832-6.
33. Osterud B, Bjørklid E. (1982). Te production and availability of tissue thromboplastin in cellular populations of whole blood exposed to various concentrations of endotoxin. An assay for detection of endotoxin. Scand J Haematol 29(2):175-84.
34. Palumbo JS, Talmage KE, Massari JV, La Jeunesse CM, Flick MJ, Kombrinck KW, Hu Z, Barney KA, Degen JL. (2007). Tumour cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms. Blood 110(1):133-41.
35. Pipinikas CP, Nair SB, Kirby RS, Carter ND, Fenske, CD (2007) Measurement of blood E2F3 mRNA in prostate cancer by quantitative RT-PCR: a preliminary study. Biomarkers 12(5):541-557.
36. Rickles FR, Levine MN. (2001). Epidemiology of thrombosis in cancer. Acta Haematol 106(1-2):6-12.
37. Rivers RP, Hathaway WE, Weston WL. (1975). Te endotoxin-induced coagulant activity of human monocytes. Br J Haematol 30(3):311-6.
38. Ruf W, Yokota N, Schafner F. (2010). Tissue factor in cancer progression and angiogenesis. Tromb Res 125 Suppl 2: S36-8.
39. Sato T, Tsujino I, Ikeda D, Ieko M, Nishimura M. (2006). Trousseau's syndrome associated with tissue factor produced by pulmonary adenocarcinoma. Torax 61(11):1009-10.
40. Sawada M, Miyake S, Ohdama S, Matsubara O, Masuda S, Yakumaru K, Yoshizawa Y (1999). Expression of tissue factor in non-small-cell lung cancers and its relationship to metastasis. Br J Cancer 79(3-4):472-7.
41. Scarpati EM, Wen D, Broze GJ Jr, Miletich JP, Flandermeier RR, Siegel NR, Sadler JE. (1987). Human tissue factor: cDNA sequence and chromosome localization of the gene. Biochemistry 26(17):5234-8.
42. Semeraro N, Colucci M. (1997). Tissue factor in health and disease. Tromb Haemost 78(1):759-64.
43. Varki A. (2007). Trousseau's syndrome: multiple defnitions and multiple mechanisms. Blood 110(6):1723-9.
44. Vázquez V, Otero LL, Laurent VE, Gabri MR, Gómez DE, Alonso DF. (2009) Molecular detection of minimal residual disease in melanoma and solid tumors. Medicina (B Aires).69 (1 Pt 2):181-90.
45. Versteeg HH, Spek CA, Peppelenbosch MP, Richel DJ. (2004). Tissue factor and cancer metastasis: the role of intracellular and extra-cellular signaling pathways. Mol Med 10(1-6):6-11.
46. Wilcox JN, Smith KM, Schwartz SM, Gordon D. (1989). Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 86(8):2839-43.
47. Zacharski LR, Schned AR, Sorenson GD. (1983). Occurrence of fbrin and tissue factor antigen in human small cell carcinoma of the lung. Cancer Res 43(8):3963-8.